Cannabinoids

Human Studies of Cannabinoids and Medicinal Cannabis 729 (1999) reported marked amelioration of both vocal and motor tics in an ...

730 P. R o b s o n related to muscle spasticity. Analgesic effects of both active drugs were similar and both superior to placeb ...

Human Studies of Cannabinoids and Medicinal Cannabis 731 or malignancy. Of 43 patients, 25 were deemed to have benefited, and th ...

732 P. R o b s o n a highly characteristic pain syndrome that is particularly difficult to treat. The au- thors note that opioid ...

Human Studies of Cannabinoids and Medicinal Cannabis 733 major limiting factor in determining patients’ acceptance of cancer che ...

734 P. R o b s o n The introduction of the highly effective (though expensive) 5-HT 3 antagonists including granisetron, ondanse ...

Human Studies of Cannabinoids and Medicinal Cannabis 735 mild or moderate categories. Drop out rates between active and placebo ...

736 P. R o b s o n 2.6 Appetite Suppression in Obesity A growing understanding of the role of central cannabinoid systems in the ...

Human Studies of Cannabinoids and Medicinal Cannabis 737 carried out a pilot study of smoked marijuana and oral THC (15 mg) in 1 ...

738 P. R o b s o n smoked cannabis on seven occasions over a 3-week period and suffered three fits during this time, though thes ...

Human Studies of Cannabinoids and Medicinal Cannabis 739 during sleep. Effects on sleep architecture were modest, but some effec ...

740 P. R o b s o n might have been a trigger for this event (Mittleman et al. 2001). Unfortunately, only 124 of the 3,882 patien ...

Human Studies of Cannabinoids and Medicinal Cannabis 741 Do any of these acute deficits persist after cannabis has been disconti ...

742 P. R o b s o n is withdrawn, difficulty in keeping consumption under control, and a preoccupa- tion with the drug that inter ...

Human Studies of Cannabinoids and Medicinal Cannabis 743 Fig. 1.Diary Card intoxication scores.BL, baseline.DB, double-blind. Pa ...

744 P. R o b s o n presence or direction of causality. Five prospective studies have been subjected to critical review (Arsenaul ...

Human Studies of Cannabinoids and Medicinal Cannabis 745 that the CB 2 -selective cannabinoid agonist AM1241 suppresses capsaici ...

746 P. R o b s o n macrophages in the gut wall. Disruption of mucosal function leads to chronic diar- rhoea and weight loss. In ...

Human Studies of Cannabinoids and Medicinal Cannabis 747 ton’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (SOD ...

748 P. R o b s o n 4.5 Drug Withdrawal Treatments In contrast to contemporary concerns about the addictive potential of cannabis ...